Compositions and methods for inhibiting cell proliferation
Disclosed are compositions and methods useful in the regulation of cell proliferation. The invention provides TGF-β (transforming growth factor β) and IGFBP-3 (insulin like growth factor binding protein 3) as ligands that engage LRP (low density lipoprotein receptor-related protein), heretofore known as TβR-V (TGF-β receptor V) and IGFBP-3 receptor, to effect a change in the phosphorylation and activation status of IRS (insulin receptor substrate) proteins. Compositions comprising TGF-β or IGFBP-3 and LRP or IRS protein are useful in the inhibition of cell proliferation and in the treatment of various diseases associated with unregulated cell proliferation.
1. A method of inhibiting cell proliferation comprising (a) contacting a cell with a receptor ligand wherein the receptor ligand is a TGF-β or an IGFBP-3 wherein the receptor ligand engages an LRP that is expressed at the surface of the cell, and (b) contacting the cell with an IRS protein such that the IRS protein is administered to the cell and the IRS protein undergoes a change in phosphorylation status, wherein said change in phosphorylation status results in the inhibition of cell proliferation.
2. The method of claim 1 wherein the receptor ligand is TGF-β.
3. The method of claim 1 wherein the receptor ligand is IGFBP-3.
4. The method of claim 1 wherein the cell is a cancer cell.
5. The method of claim 1 wherein the cell is in a patient.